Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity

Douglas G. Gold, Robert C. Miller, Melva E. Pinn, Thomas G. Osborn, Ivy A. Petersen, Paul D. Brown

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

No method reliably identifies which patients with connective tissue disorders are at greatest risk of radiotherapy-related complications. Building on our prior experience, we postulated that disease severity, as measured by the number of organ systems involved, may predict chronic radiation toxicity risk.

Original languageEnglish (US)
Pages (from-to)127-131
Number of pages5
JournalRadiotherapy and Oncology
Volume87
Issue number1
DOIs
StatePublished - Apr 1 2008

Keywords

  • Adverse effects
  • Connective tissue disorder
  • Radiotherapy
  • Scleroderma
  • Systemic lupus erythematosus
  • Systemic sclerosis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity'. Together they form a unique fingerprint.

  • Cite this